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Abstract: Objective: To assess the clinic effect of percutaneous coronary intervention in the treatment of acute myocar-
dial infarction. Methods: 90 patients with acute myocardial infarction in our hospital were chosen to be research objects 
and they were divided into two groups: control group and research group. Patients in control group were only treated by 
thrombolytic therapy while those in research group were further treated by percutaneous coronary intervention on 
the basis of this treatment. Result: The efficacy of research group was higher than that in control group. The incidence 
of adverse events was 4.44%, which is lower than that in control group. Conclusion: We should effectively apply per-
cutaneous coronary intervention in treating acute myocardial infarction so as to improve the cardiac function of the pa-
tients. In addition, this treatment is safer and will lower the incidence of heart and renal failure. 
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1 Introduction 
Acute myocardial infarction is a very common se-
vere case in clinic treatment. It frequently occurred in the 
mid-aged and the elderly group. When patients were at-
tacked by such disease, there is always a significant 
higher level of myocardial enzyme series in their bodies, 
which will badly affect their daily life. With reference to 
the clinic treatment of myocardial infarction and a fur-
ther exploration on this issue, we find that the efficacy is 
significantly raised when applying percutaneous coro-
nary intervention in the treatment, which will highly im-
prove the patients’ health conditions by raising their car-
diac function and will also lower the case fatality.  
2 Data and methods 
2.1 Data 
From March 2017 to March 2019, 90 patients with 
acute myocardial infarction in our hospital were chosen 
to be research objects and they were divided into two 
groups: control group and research group[1]. Among the 
45 patients in control group, there are 28 male patients 
and 17 female patients with an average age of 
58.76±7.04. And among the 45 patients in research group, 
26 are male and 19 are female, with an average age of 
57.47±6.34. Since there was no significant difference in 
data between the two groups, the data are comparable.    
2.2 Methods 
Patients in control group were treated by thrombo-
lytic therapy, that is to say, they were treated by intrave-
nous infusion by giving 500,000 units of urokinase when 
diluted to 1 million units and mixed with 100ml of nor-
mal saline[2]. However, patients in research group will be 
further treated by percutaneous coronary intervention on 
the basis of this treatment. Detail treatments are as fol-
lows: firstly, transferring patients and then treating 
them by percutaneous coronary intervention: patients 
who are not suitable for thrombolytic therapy should be 
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transferred to hospitals with percutaneous coronary in-
tervention[3]. Secondly, directly treating patients by per-
cutaneous coronary intervention: to further dredge in-
fraction artery 12 hours before the outbreak and the 
treatment time shall be controlled within 90 minutes. 
2.3 Observation index and assessment 
standard 
2.3.1 Observation index 
To figure out and compare the incidence of adverse 
events and the changes of patients’ cardiac function lev-
el before and after the treatment. 
2.3.2 Efficacy assessment standard 
Excellent Efficacy: the patients’ conditions of coro-
nary artery stenoses significantly improved after treat-
ment; Average efficacy: the patients don’t occur angina 
and have no adverse reaction after treatment; Naught 
efficacy: there are no improvement in acute myocardial 
infarction or the patients died after treatment[4]. 
2.4 Statistical methods  
 Statistic software SPSS22.0 is used to analyze the 
data. The measurement data are expressed as “x±s” and 
will be testified by t. The adoption rate of enumeration 
data is expressed by % and is testified by X2.  P＜0.05 
represents the difference. When the probability of the 
difference is below 0.05, the data bears statistical signif-
icance. 
3. Results 
3.1 Comparison of incidence of adverse 
events between two groups 
The incidence of adverse events in research group is 
4.44%, lower than 17.78% in control group. And this 
difference bears great statistical significance (P＜0.05). 
See in Table 1. 
 
Table 1. The incidence of adverse events in two groups [n(%)]
Groups Cases  Hemmorrhage  Renal failure Angina  Incidence  
Research Group 45 0 1 (2.22) 1 (2.22) 2 (4.44) 
Control Group 45 3 (6.67) 3 (6.67) 3 (6.67) 9 (20.00) 
X2     4.050 
p     0.044 
 




The total efficacy in research group is higher than 
that in control group and the difference bears great statis-
tical significance (P＜0.05). See in Table 2. 
Table 2. Comparison of Clinic efficacy between two groups
Groups  Cases Excellent efficacy Average efficacy  Naught efficacy Total efficacy 
Research Group 45 20 (44.44) 24 (53.33) 1 (2.22) 44 (97.78) 
Control Group 45 18 (40.00) 20 (44.44) 7 (15.56) 38 (84.44) 
X2     4.939 
p     0.026 
4. Discussion 
Acute myocardial infarction is characterized by se-
verity and urgency in outbreak. It is usually caused by an 
emergency block in coronary artery in patients’ body[5]. 
If the patients don’t get immediate treatment, the size of 
myocardial infarction will gradually expand, thus leading 
to arrhythmia, renal failure as well as shock. What’s 
worse, the patients may probably get a sudden death 
when their conditions get worse, which exerts a great 
threat to their physical safety. The experimental results 
show that the total efficacy of research group is 97.78% 
and is much higher than that of 84.44% in control group.  
 
In general, the incidence of adverse events happened in 
patients with acute myocardial infarction is gradually 
declining after percutaneous coronary intervention and is 
far lower than that of patients treated only by thrombo-
lytic therapy. At the same time, when treated by percuta-
neous coronary intervention, the patients will be better 
treated and all their index of cardiac function will be 
improved, which is helpful to further control their treat-
ment efficacy and improve their block in coronary ar-
tery[6]. As a doctor, it is necessary to choose appropriate 
treatment for the patients when treating. Only when we 
scientifically carry out our treatment, shall we better cure 
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our patients who are suffering myocardial infarction.  
Percutaneous coronary intervention is a form of op-
erative treatment, which needs to perform coronary ar-
tery bypass operation for the patients when operating. It 
will use intracoronary stenting to further improve pa-
tients’ conditions of myocardial infarction so as to 
achieve an effective adjustment to their conditions of 
myocardial infarction[7]. Meanwhile, it shall effectively 
improve their conditions of coronary artery stenoses by 
percutaneous coronary intervention so as to ensure the 
preservation and recovery of their cardiopulmonary 
function. In addition, by using percutaneous coronary 
intervention, it shall further improve their conditions of 
coronary arteriosclerosis and dredge their clogged artery 
so as to raise the dredge capability of the coronary artery 
and help improve patients’ conditions. It can be find from 
clinic experiment that percutaneous coronary interven-
tion had sound efficacy in treating patients with acute 
myocardial infarction[8]. It can quickly change the condi-
tions of coronary artery stenoses and improve their car-
diopulmonary function and cardiovascular supply, so as 
to get enough time for treatment. And after treatment, it 
shall effectively control the incidence of adverse events 
and improve patients’ conditions of myocardial infarc-
tion.  
In conclusion, we should actively apply percutane-
ous coronary intervention in the treatment of acute myo-
cardial infarction so as to improve patients’ cardiopul-
monary function. Since its low incidence of heart and 
renal failure, safety and significant treatment efficacy in 
treatment, percutaneous coronary intervention bears 
great significance in clinic treatment. 
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